Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Correction to "Combining Protein Ratio p-Values as a Pragmatic Approach to the Analysis of Multirun iTRAQ Experiments".

Pascovici D, Song X, Solomon PS, Winterberg B, Mirzaei M, Goodchild A, Stanley WC, Liu J, Molloy MP.

J Proteome Res. 2015 Nov 6;14(11):4944. doi: 10.1021/acs.jproteome.5b00897. Epub 2015 Oct 8. No abstract available.

PMID:
26448159
2.

Effects of environmental stress following myocardial infarction on behavioral measures and heart failure progression: The influence of isolated and group housing conditions.

Kop WJ, Galvao TF, Synowski SJ, Xu W, Can A, O'Shea KM, Gould TD, Stanley WC.

Physiol Behav. 2015 Dec 1;152(Pt A):168-74. doi: 10.1016/j.physbeh.2015.09.024. Epub 2015 Sep 28.

PMID:
26423786
3.

Combining protein ratio p-values as a pragmatic approach to the analysis of multirun iTRAQ experiments.

Pascovici D, Song X, Solomon PS, Winterberg B, Mirzaei M, Goodchild A, Stanley WC, Liu J, Molloy MP.

J Proteome Res. 2015 Feb 6;14(2):738-46. doi: 10.1021/pr501091e. Epub 2015 Jan 13. Erratum in: J Proteome Res. 2015 Nov 6;14(11):4944.

PMID:
25495031
4.

Cardiac mitochondrial proteome dynamics with heavy water reveals stable rate of mitochondrial protein synthesis in heart failure despite decline in mitochondrial oxidative capacity.

Shekar KC, Li L, Dabkowski ER, Xu W, Ribeiro RF Jr, Hecker PA, Recchia FA, Sadygov RG, Willard B, Kasumov T, Stanley WC.

J Mol Cell Cardiol. 2014 Oct;75:88-97. doi: 10.1016/j.yjmcc.2014.06.014. Epub 2014 Jul 1.

5.

Effect of a high-protein diet on development of heart failure in response to pressure overload.

Ribeiro RF Jr, Dabkowski ER, O'Connell KA, Xu W, Galvao Tde F, Hecker PA, Shekar KC, Stefanon I, Stanley WC.

Appl Physiol Nutr Metab. 2014 Feb;39(2):238-47. doi: 10.1139/apnm-2013-0274. Epub 2013 Sep 11.

6.

Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart.

Vimercati C, Qanud K, Mitacchione G, Sosnowska D, Ungvari Z, Sarnari R, Mania D, Patel N, Hintze TH, Gupte SA, Stanley WC, Recchia FA.

Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H709-17. doi: 10.1152/ajpheart.00783.2013. Epub 2014 Jan 10.

7.

Dietary saturated fat and docosahexaenoic acid differentially effect cardiac mitochondrial phospholipid fatty acyl composition and Ca(2+) uptake, without altering permeability transition or left ventricular function.

O'Connell KA, Dabkowski ER, de Fatima Galvao T, Xu W, Daneault C, de Rosiers C, Stanley WC.

Physiol Rep. 2013 Jun;1(1):e00009. doi: 10.1002/phy2.9. Epub 2013 Jun 12.

8.

Evaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy.

Stanley WC, Cox JW, Asemu G, O'Connell KA, Dabkowski ER, Xu W, Ribeiro RF Jr, Shekar KC, Hoag SW, Rastogi S, Sabbah HN, Daneault C, des Rosiers C.

J Cardiovasc Transl Res. 2013 Dec;6(6):1000-10. doi: 10.1007/s12265-013-9511-y. Epub 2013 Sep 25.

9.

Introduction to special issue on cardiac metabolism in hypertrophy and failure.

Stanley WC.

Heart Fail Rev. 2013 Sep;18(5):553. doi: 10.1007/s10741-013-9408-5. No abstract available.

PMID:
24045930
10.

Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failure.

Dabkowski ER, O'Connell KA, Xu W, Ribeiro RF Jr, Hecker PA, Shekar KC, Daneault C, Des Rosiers C, Stanley WC.

Cardiovasc Drugs Ther. 2013 Dec;27(6):499-510. doi: 10.1007/s10557-013-6487-4.

11.

Update on innovative initiatives for the American Journal of Physiology-Heart and Circulatory Physiology.

Stanley WC, Keehan KH.

Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1045-9. doi: 10.1152/ajpheart.00082.2013. Epub 2013 Mar 1. No abstract available.

12.

Assessment of cardiac proteome dynamics with heavy water: slower protein synthesis rates in interfibrillar than subsarcolemmal mitochondria.

Kasumov T, Dabkowski ER, Shekar KC, Li L, Ribeiro RF Jr, Walsh K, Previs SF, Sadygov RG, Willard B, Stanley WC.

Am J Physiol Heart Circ Physiol. 2013 May;304(9):H1201-14. doi: 10.1152/ajpheart.00933.2012. Epub 2013 Mar 1.

13.

Cardiomyocyte-specific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunction.

Wang H, Sreenivasan U, Gong DW, O'Connell KA, Dabkowski ER, Hecker PA, Ionica N, Konig M, Mahurkar A, Sun Y, Stanley WC, Sztalryd C.

J Lipid Res. 2013 Apr;54(4):953-65. doi: 10.1194/jlr.M032466. Epub 2013 Jan 23.

14.

Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Hecker PA, Leopold JA, Gupte SA, Recchia FA, Stanley WC.

Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H491-500. doi: 10.1152/ajpheart.00721.2012. Epub 2012 Dec 15. Review.

15.

Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion.

Asemu G, O'Connell KA, Cox JW, Dabkowski ER, Xu W, Ribeiro RF Jr, Shekar KC, Hecker PA, Rastogi S, Sabbah HN, Hoppel CL, Stanley WC.

Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H514-28. doi: 10.1152/ajpheart.00674.2012. Epub 2012 Dec 15.

16.

Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure.

Hecker PA, Lionetti V, Ribeiro RF Jr, Rastogi S, Brown BH, O'Connell KA, Cox JW, Shekar KC, Gamble DM, Sabbah HN, Leopold JA, Gupte SA, Recchia FA, Stanley WC.

Circ Heart Fail. 2013 Jan;6(1):118-26. doi: 10.1161/CIRCHEARTFAILURE.112.969576. Epub 2012 Nov 20.

17.

Metabolomic analysis of two different models of delayed preconditioning.

Bravo C, Kudej RK, Yuan C, Yoon S, Ge H, Park JY, Tian B, Stanley WC, Vatner SF, Vatner DE, Yan L.

J Mol Cell Cardiol. 2013 Feb;55:19-26. doi: 10.1016/j.yjmcc.2012.10.012. Epub 2012 Nov 2.

18.

Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.

Galvao TF, Khairallah RJ, Dabkowski ER, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN, Rastogi S, Daneault C, Des Rosiers C, Stanley WC.

Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H12-21. doi: 10.1152/ajpheart.00657.2012. Epub 2012 Oct 26.

19.

Common mechanisms for calorie restriction and adenylyl cyclase type 5 knockout models of longevity.

Yan L, Park JY, Dillinger JG, De Lorenzo MS, Yuan C, Lai L, Wang C, Ho D, Tian B, Stanley WC, Auwerx J, Vatner DE, Vatner SF.

Aging Cell. 2012 Dec;11(6):1110-20. doi: 10.1111/acel.12013. Epub 2012 Oct 17.

20.

Acute vagal stimulation attenuates cardiac metabolic response to β-adrenergic stress.

Vimercati C, Qanud K, Ilsar I, Mitacchione G, Sarnari R, Mania D, Faulk R, Stanley WC, Sabbah HN, Recchia FA.

J Physiol. 2012 Dec 1;590(23):6065-74. doi: 10.1113/jphysiol.2012.241943. Epub 2012 Sep 10.

21.

Chronic hypoxia impairs cytochrome oxidase activity via oxidative stress in selected fetal Guinea pig organs.

Al-Hasan YM, Evans LC, Pinkas GA, Dabkowski ER, Stanley WC, Thompson LP.

Reprod Sci. 2013 Mar;20(3):299-307. doi: 10.1177/1933719112453509. Epub 2012 Aug 24.

22.

Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart.

Papanicolaou KN, Kikuchi R, Ngoh GA, Coughlan KA, Dominguez I, Stanley WC, Walsh K.

Circ Res. 2012 Sep 28;111(8):1012-26. Epub 2012 Aug 17.

23.

Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets.

Hecker PA, Mapanga RF, Kimar CP, Ribeiro RF Jr, Brown BH, O'Connell KA, Cox JW, Shekar KC, Asemu G, Essop MF, Stanley WC.

Am J Physiol Endocrinol Metab. 2012 Oct 15;303(8):E959-72. doi: 10.1152/ajpendo.00202.2012. Epub 2012 Jul 24.

24.

Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids.

Khairallah RJ, Kim J, O'Shea KM, O'Connell KA, Brown BH, Galvao T, Daneault C, Des Rosiers C, Polster BM, Hoppel CL, Stanley WC.

PLoS One. 2012;7(3):e34402. doi: 10.1371/journal.pone.0034402. Epub 2012 Mar 30.

25.

Plasma proteome dynamics: analysis of lipoproteins and acute phase response proteins with 2H2O metabolic labeling.

Li L, Willard B, Rachdaoui N, Kirwan JP, Sadygov RG, Stanley WC, Previs S, McCullough AJ, Kasumov T.

Mol Cell Proteomics. 2012 Jul;11(7):M111.014209. doi: 10.1074/mcp.M111.014209. Epub 2012 Mar 5.

26.

Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

Stanley WC, Dabkowski ER, Ribeiro RF Jr, O'Connell KA.

Circ Res. 2012 Mar 2;110(5):764-76. doi: 10.1161/CIRCRESAHA.111.253104. Review.

27.

High-sugar intake does not exacerbate metabolic abnormalities or cardiac dysfunction in genetic cardiomyopathy.

Hecker PA, Galvao TF, O'Shea KM, Brown BH, Henderson R Jr, Riggle H, Gupte SA, Stanley WC.

Nutrition. 2012 May;28(5):520-6. doi: 10.1016/j.nut.2011.09.017. Epub 2012 Feb 2.

28.

Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids.

Stanley WC, Khairallah RJ, Dabkowski ER.

Curr Opin Clin Nutr Metab Care. 2012 Mar;15(2):122-6. doi: 10.1097/MCO.0b013e32834fdaf7. Review.

29.

Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death.

Papanicolaou KN, Ngoh GA, Dabkowski ER, O'Connell KA, Ribeiro RF Jr, Stanley WC, Walsh K.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H167-79. doi: 10.1152/ajpheart.00833.2011. Epub 2011 Oct 28.

30.

High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects.

Galvao TF, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN, Rastogi S, Daneault C, Des Rosiers C, Stanley WC.

Cardiovasc Res. 2012 Jan 1;93(1):24-32. doi: 10.1093/cvr/cvr258. Epub 2011 Sep 29.

31.

Perilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondria.

Wang H, Sreenivasan U, Hu H, Saladino A, Polster BM, Lund LM, Gong DW, Stanley WC, Sztalryd C.

J Lipid Res. 2011 Dec;52(12):2159-68. doi: 10.1194/jlr.M017939. Epub 2011 Aug 31. Erratum in: J Lipid Res. 2013 Dec;54(12):3539. Sreenevasan, Urmilla [corrected to Sreenivasan, Urmilla].

32.

Modulating fatty acid oxidation in heart failure.

Lionetti V, Stanley WC, Recchia FA.

Cardiovasc Res. 2011 May 1;90(2):202-9. doi: 10.1093/cvr/cvr038. Epub 2011 Feb 2. Review.

33.

Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes.

Papanicolaou KN, Khairallah RJ, Ngoh GA, Chikando A, Luptak I, O'Shea KM, Riley DD, Lugus JJ, Colucci WS, Lederer WJ, Stanley WC, Walsh K.

Mol Cell Biol. 2011 Mar;31(6):1309-28. doi: 10.1128/MCB.00911-10. Epub 2011 Jan 18.

34.

Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice.

Hecker PA, O'Shea KM, Galvao TF, Brown BH, Stanley WC.

Horm Metab Res. 2011 Feb;43(2):100-5. doi: 10.1055/s-0030-1269898. Epub 2010 Dec 16.

PMID:
21165812
35.

Lipotoxicity and the development of heart failure: moving from mouse to man.

Stanley WC, Recchia FA.

Cell Metab. 2010 Dec 1;12(6):555-6. doi: 10.1016/j.cmet.2010.11.016.

36.

Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotection.

Taegtmeyer H, Stanley WC.

J Mol Cell Cardiol. 2011 Jan;50(1):2-5. doi: 10.1016/j.yjmcc.2010.09.014. Epub 2010 Sep 24. No abstract available.

37.

ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin.

O'Shea KM, Chess DJ, Khairallah RJ, Hecker PA, Lei B, Walsh K, Des Rosiers C, Stanley WC.

Lipids Health Dis. 2010 Sep 6;9:95. doi: 10.1186/1476-511X-9-95.

38.

Treatment with docosahexaenoic acid, but not eicosapentaenoic acid, delays Ca2+-induced mitochondria permeability transition in normal and hypertrophied myocardium.

Khairallah RJ, O'Shea KM, Brown BH, Khanna N, Des Rosiers C, Stanley WC.

J Pharmacol Exp Ther. 2010 Oct;335(1):155-62. doi: 10.1124/jpet.110.170605. Epub 2010 Jul 12.

39.

Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition.

Khairallah RJ, Sparagna GC, Khanna N, O'Shea KM, Hecker PA, Kristian T, Fiskum G, Des Rosiers C, Polster BM, Stanley WC.

Biochim Biophys Acta. 2010 Aug;1797(8):1555-62. doi: 10.1016/j.bbabio.2010.05.007. Epub 2010 May 21.

40.

Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.

O'Shea KM, Chess DJ, Khairallah RJ, Rastogi S, Hecker PA, Sabbah HN, Walsh K, Stanley WC.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1639-45. doi: 10.1152/ajpheart.00957.2009. Epub 2010 Mar 26.

41.

Myocardial fatty acid metabolism in health and disease.

Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC.

Physiol Rev. 2010 Jan;90(1):207-58. doi: 10.1152/physrev.00015.2009. Review.

42.

[Overview on omega-3 polyunsaturated fatty acids and heart failure].

Duda MK, O'Shea KM, Stanley WC.

Kardiol Pol. 2010;68 Suppl 5:S400-4. Review. Polish.

PMID:
22134993
43.

Dipropionylcysteine ethyl ester compensates for loss of citric acid cycle intermediates during post ischemia reperfusion in the pig heart.

Kasumov T, Sharma N, Huang H, Kombu RS, Cendrowski A, Stanley WC, Brunengraber H.

Cardiovasc Drugs Ther. 2009 Dec;23(6):459-69. doi: 10.1007/s10557-009-6208-1.

44.

Does junk food lead to heart failure? Importance of dietary macronutrient composition in hypertension.

Stanley WC, Shah KB, Essop MF.

Hypertension. 2009 Dec;54(6):1209-10. doi: 10.1161/HYPERTENSIONAHA.109.128660. Epub 2009 Oct 19. No abstract available.

45.

A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload.

Chess DJ, Khairallah RJ, O'Shea KM, Xu W, Stanley WC.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1585-93. doi: 10.1152/ajpheart.00599.2009. Epub 2009 Sep 18.

46.

Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.

O'Shea KM, Khairallah RJ, Sparagna GC, Xu W, Hecker PA, Robillard-Frayne I, Des Rosiers C, Kristian T, Murphy RC, Fiskum G, Stanley WC.

J Mol Cell Cardiol. 2009 Dec;47(6):819-27. doi: 10.1016/j.yjmcc.2009.08.014. Epub 2009 Aug 22.

47.

The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling.

Shah KB, Duda MK, O'Shea KM, Sparagna GC, Chess DJ, Khairallah RJ, Robillard-Frayne I, Xu W, Murphy RC, Des Rosiers C, Stanley WC.

Hypertension. 2009 Sep;54(3):605-11. doi: 10.1161/HYPERTENSIONAHA.109.135806. Epub 2009 Jul 13.

48.

Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance.

Solomon TP, Haus JM, Marchetti CM, Stanley WC, Kirwan JP.

Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E552-9. doi: 10.1152/ajpendo.00220.2009. Epub 2009 Jun 16.

49.

omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.

Duda MK, O'Shea KM, Stanley WC.

Cardiovasc Res. 2009 Oct 1;84(1):33-41. doi: 10.1093/cvr/cvp169. Epub 2009 May 27. Review.

50.

Chronic treatment with the peroxisome proliferator-activated receptor alpha agonist Wy-14,643 attenuates myocardial respiratory capacity and contractile function.

Zungu M, Young ME, Stanley WC, Essop MF.

Mol Cell Biochem. 2009 Oct;330(1-2):55-62. doi: 10.1007/s11010-009-0100-y. Epub 2009 Apr 10.

PMID:
19360380

Supplemental Content

Loading ...
Support Center